Curcumin tested in human clinical trials have shown anti-cancer activity promise. In contrast to using chemotherapy drugs, Curcumin is tolerated and considered safe.
Complaints of the gastrointestinal tract, simple digestive concerns, or those of cancer, show great promise with the use of Curcumin.
Curcumin and turmeric were found in numerous clinical studies to decrease inflammatory responses in the body, like TNF-a and inhibit the growth of cancer-causing proteins. By modulating NFK-b, Curcumin kills cancer cells while preserving non-cancerous cells. One mechanism reported to support such remarkable claims is curcumins’ ability to assist in the production of glutathione, an antioxidant, slowing the progression of cancer. This finding was of most remark in colon and pancreatic cancer.
Further research is underway to investigate the possibility of using Curcumin and turmeric in the treatment of multifarious conditions.
Biomed Res Int. 2013 Jul 1., Int Immunopharmacol.2012 Feb;12
Thank you for sharing your email address with us.
We will add you to our list and you will begin receiving emails from the nEI when we have important news to share.
All Rights Reserved | nutraMetix Educational Institute